Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Iovance Biotherapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 238 | 1 | 242 | +5 |
| Shares | 159.3M | 20 | 154.2M | −5.11M (−3.2%) |
| Value | $1.75B | $221 | $1.48B | −$269.3M (−15.4%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (31)
Institutions that held Iovance Biotherapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (26)
Institutions that held Iovance Biotherapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Farallon Capital Management, L.L.C. | 3,176,773 | $35.1M |
| California Public Employees Retirement System | 271,534 | $3.00M |
| ETF Managers Group, LLC | 114,431 | $1.25M |
| Bayesian Capital Management, LP | 107,782 | $1.19M |
| Kettle Hill Capital Management, LLC | 81,958 | $905.0K |
| SG Americas Securities, LLC | 81,549 | $900.0K |
| National Bank of Canada | 71,000 | $784.0K |
| Bokf, NA | 40,248 | $444.0K |
| Weiss Multi-Strategy Advisers LLC | 29,996 | $331.0K |
| Walleye Trading LLC | 24,704 | $273.0K |
| Walleye Capital LLC | 14,467 | $160.0K |
| HighTower Advisors, LLC | 12,050 | $132.0K |
| HSBC Holdings PLC | 10,744 | $118.0K |
| Mackenzie Financial Corp | 10,325 | $114.0K |
| Clear Harbor Asset Management, LLC | 6,625 | $73.0K |
| AdvisorNet Financial, Inc | 2,283 | $25.0K |
| Captrust Financial Advisors | 1,474 | $16.0K |
| Glassman Wealth Services | 560 | $6.00K |
| Umb Bank N A | 355 | $4.00K |
| ACG Wealth | 200 | $2.00K |
| Jefferies Group LLC | 121 | $1.34K |
| Signaturefd, LLC | 51 | $1.00K |
| Ellevest, Inc. | 100 | $1.00K |
| Concord Wealth Partners | 90 | $1.00K |
| Meeder Asset Management Inc | 14 | $0 |
| Dark Forest Capital Management LP | 40 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Iovance Biotherapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 20 | $221 |